$KOSP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in KOS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in KOS PHARMACEUTICALS INC. Get notifications about new insider transactions in KOS PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 16.38 | 30,000 | 491,400 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 24.24 | 5,000 | 121,200 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 25.96 | 20,000 | 519,200 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 17.94 | 5,000 | 89,700 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 16.78 | 20,000 | 335,600 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 13.81 | 5,000 | 69,050 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 20.69 | 15,000 | 310,350 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 4.97 | 3,000 | 14,910 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 4.28 | 15,000 | 64,200 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 7.14 | 15,000 | 107,100 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 7.75 | 3,000 | 23,250 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 11.16 | 10,000 | 111,600 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | D | 24.69 | 5,000 | 123,450 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Sell | U | 78.00 | 5,000 | 390,000 | 0 | 5 K to 0 (-100.00 %) |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 46.24 | 20,000 | 924,800 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 49.24 | 10,000 | 492,400 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 32.01 | 30,000 | 960,300 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 20.90 | 10,000 | 209,000 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 16.38 | 30,000 | 491,400 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 17.94 | 5,000 | 89,700 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 16.78 | 20,000 | 335,600 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 13.81 | 5,000 | 69,050 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 20.69 | 15,000 | 310,350 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 4.97 | 3,000 | 14,910 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 4.28 | 15,000 | 64,200 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 7.14 | 15,000 | 107,100 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 7.75 | 3,000 | 23,250 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | D | 11.16 | 10,000 | 111,600 | 0 | |
| Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | U | 78.00 | 5,000 | 390,000 | 0 | 5 K to 0 (-100.00 %) |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Option Exercise | A | 44.96 | 1,875 | 84,300 | 1,875 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Option Exercise | D | 44.15 | 1,875 | 82,781 | 625 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | A | 36.84 | 10,000 | 368,400 | 10,000 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 35.58 | 10,000 | 355,800 | 10,000 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ADAMS ADRIAN | President & CEO | Option Exercise | A | 44.96 | 52,500 | 2,360,400 | 52,500 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ADAMS ADRIAN | President & CEO | Option Exercise | D | 44.15 | 52,500 | 2,317,875 | 17,500 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ADAMS ADRIAN | President & CEO | Option Exercise | A | 33.44 | 25,000 | 836,000 | 25,000 | |
| Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ADAMS ADRIAN | President & CEO | Option Exercise | D | 17.97 | 25,000 | 449,250 | 75,000 | |
| Dec 13 2006 | KOSP | KOS PHARMACEUTICAL ... | MADIAS NICHOLAOS E | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| Dec 13 2006 | KOSP | KOS PHARMACEUTICAL ... | MADIAS NICHOLAOS E | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Nov 13 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 20,000 | 0 | 1,420,001 | 1.4 M to 1.4 M (+1.43 %) |
| Nov 13 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 20,000 | 0 | 5,296,651 | 5.3 M to 5.3 M (-0.38 %) |
| Nov 13 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 20,000 | 0 | 5,296,651 | 5.3 M to 5.3 M (-0.38 %) |
| Nov 13 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 20,000 | 0 | 1,420,001 | 1.4 M to 1.4 M (+1.43 %) |
| Nov 08 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | M | 35.58 | 12,500 | 444,750 | 20,000 | |
| Nov 08 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Sell | S | 76.95 | 12,500 | 961,875 | 9,819 | 22.3 K to 9.8 K (-56.01 %) |
| Nov 08 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Buy | M | 35.58 | 12,500 | 444,750 | 22,319 | 9.8 K to 22.3 K (+127.30 %) |
| Nov 01 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 2,844,410 | 0 | 1,400,001 | 4.2 M to 1.4 M (-67.02 %) |
| Nov 01 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 2,844,410 | 0 | 1,400,001 | 4.2 M to 1.4 M (-67.02 %) |
| Sep 27 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 14,708 | 0 | 4,244,411 | 4.2 M to 4.2 M (+0.35 %) |
| Sep 27 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 14,708 | 0 | 4,244,411 | 4.2 M to 4.2 M (+0.35 %) |
| Jul 11 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS STEVEN | Director | Gift | G | 0.00 | 68,453 | 0 | 68,453 | 0 to 68.5 K |
| May 17 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Option Exercise | A | 47.46 | 632,111 | 29,999,988 | 632,111 | |
| May 17 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Option Exercise | A | 47.46 | 632,111 | 29,999,988 | 632,111 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Grant | A | 0.00 | 5,000 | 0 | 5,316,651 | 5.3 M to 5.3 M (+0.09 %) |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 5,316,651 | 5.3 M to 5.3 M (+0.09 %) |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS STEVEN | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS STEVEN | Director | Grant | A | 0.00 | 5,000 | 0 | 127,423 | 122.4 K to 127.4 K (+4.08 %) |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | BRADEMAS JOHN | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | Ferro Kevin | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | Ferro Kevin | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | NOVITCH MARK M D | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | NOVITCH MARK M D | Director | Grant | A | 0.00 | 5,000 | 0 | 7,000 | 2 K to 7 K (+250.00 %) |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | Pruitt William D | Director | Option Exercise | A | 46.24 | 20,000 | 924,800 | 20,000 | |
| May 02 2006 | KOSP | KOS PHARMACEUTICAL ... | Pruitt William D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Mar 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Option Exercise | M | 19.50 | 5,000 | 97,500 | 66,000 | |
| Mar 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Sell | S | 50.00 | 5,000 | 250,000 | 12,908 | 17.9 K to 12.9 K (-27.92 %) |
| Mar 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Buy | M | 19.50 | 5,000 | 97,500 | 17,908 | 12.9 K to 17.9 K (+38.74 %) |
| Mar 21 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 25,718 | 0 | 4,229,703 | 4.2 M to 4.2 M (+0.61 %) |
| Mar 21 2006 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 25,718 | 0 | 4,229,703 | 4.2 M to 4.2 M (+0.61 %) |
| Mar 20 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Option Exercise | M | 12.97 | 3,200 | 41,504 | 0 | |
| Mar 20 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Option Exercise | M | 19.50 | 3,800 | 74,100 | 38,200 | |
| Mar 20 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Sell | S | 50.80 | 3,200 | 162,560 | 9,442 | 12.6 K to 9.4 K (-25.31 %) |
| Mar 20 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Buy | M | 12.97 | 3,200 | 41,504 | 12,642 | 9.4 K to 12.6 K (+33.89 %) |
| Mar 20 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Sell | S | 50.80 | 3,800 | 193,040 | 9,442 | 13.2 K to 9.4 K (-28.70 %) |
| Mar 20 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Buy | M | 19.50 | 3,800 | 74,100 | 13,242 | 9.4 K to 13.2 K (+40.25 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Option Exercise | M | 19.50 | 16,250 | 316,875 | 16,250 | |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Option Exercise | M | 22.55 | 12,500 | 281,875 | 0 | |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Sell | S | 49.00 | 16,250 | 796,250 | 14,099 | 30.3 K to 14.1 K (-53.54 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Buy | M | 19.50 | 16,250 | 316,875 | 30,349 | 14.1 K to 30.3 K (+115.26 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Sell | S | 49.00 | 12,500 | 612,500 | 14,099 | 26.6 K to 14.1 K (-46.99 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Buy | M | 22.55 | 12,500 | 281,875 | 26,599 | 14.1 K to 26.6 K (+88.66 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Option Exercise | M | 22.55 | 7,500 | 169,125 | 0 | |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Option Exercise | M | 22.55 | 2,500 | 56,375 | 7,500 | |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Sell | S | 48.80 | 7,500 | 366,000 | 17,433 | 24.9 K to 17.4 K (-30.08 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Buy | M | 22.55 | 7,500 | 169,125 | 24,933 | 17.4 K to 24.9 K (+43.02 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Sell | S | 49.40 | 2,500 | 123,500 | 17,433 | 19.9 K to 17.4 K (-12.54 %) |
| Mar 15 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Buy | M | 22.55 | 2,500 | 56,375 | 19,993 | 17.5 K to 20 K (+14.29 %) |
| Mar 14 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Option Exercise | M | 19.50 | 5,000 | 97,500 | 66,000 | |
| Mar 14 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Sell | S | 50.00 | 5,000 | 250,000 | 12,908 | 17.9 K to 12.9 K (-27.92 %) |
| Mar 14 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Buy | M | 19.50 | 5,000 | 97,500 | 17,908 | 12.9 K to 17.9 K (+38.74 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Option Exercise | M | 22.55 | 2,500 | 56,375 | 10,000 | |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Option Exercise | M | 19.50 | 7,322 | 142,779 | 12,500 | |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Sell | S | 47.50 | 2,500 | 118,750 | 17,433 | 19.9 K to 17.4 K (-12.54 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Buy | M | 22.55 | 2,500 | 56,375 | 19,933 | 17.4 K to 19.9 K (+14.34 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Sell | S | 45.00 | 4,822 | 216,990 | 17,433 | 22.3 K to 17.4 K (-21.67 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Sell | S | 46.62 | 2,500 | 116,550 | 22,255 | 24.8 K to 22.3 K (-10.10 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Buy | M | 19.50 | 7,322 | 142,779 | 24,755 | 17.4 K to 24.8 K (+42.00 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Option Exercise | M | 19.50 | 5,178 | 100,971 | 19,822 | |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Sell | S | 45.01 | 5,178 | 233,062 | 17,433 | 22.6 K to 17.4 K (-22.90 %) |
| Mar 09 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Buy | M | 19.50 | 5,178 | 100,971 | 22,611 | 17.4 K to 22.6 K (+29.70 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | ADAMS ADRIAN | President & CEO | Option Exercise | A | 44.86 | 58,800 | 2,637,768 | 58,800 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | ADAMS ADRIAN | President & CEO | Grant | A | 0.00 | 29,400 | 0 | 33,145 | 3.7 K to 33.1 K (+785.05 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KOVEN ANDREW I | EVP, General Counse ... | Option Exercise | A | 44.86 | 20,000 | 897,200 | 20,000 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KOVEN ANDREW I | EVP, General Counse ... | Grant | A | 0.00 | 10,000 | 0 | 10,304 | 304 to 10.3 K (+3,289.47 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Option Exercise | A | 44.86 | 18,000 | 807,480 | 18,000 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Grant | A | 0.00 | 9,000 | 0 | 12,887 | 3.9 K to 12.9 K (+231.54 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | BELL DANIEL M | Director | Option Exercise | A | 44.86 | 18,000 | 807,480 | 18,000 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | BELL DANIEL M | Director | Grant | A | 0.00 | 9,000 | 0 | 45,477 | 36.5 K to 45.5 K (+24.67 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | A | 44.86 | 19,000 | 852,340 | 19,000 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Grant | A | 0.00 | 9,500 | 0 | 9,790 | 290 to 9.8 K (+3,275.86 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Option Exercise | A | 44.86 | 7,900 | 354,394 | 7,900 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | BALDINI ROBERT E | Director | Grant | A | 0.00 | 3,950 | 0 | 17,336 | 13.4 K to 17.3 K (+29.51 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Option Exercise | A | 44.86 | 15,000 | 672,900 | 15,000 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | RODRIGUEZ JUAN F | SVP, Controller & C ... | Grant | A | 0.00 | 7,500 | 0 | 9,410 | 1.9 K to 9.4 K (+392.67 %) |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Option Exercise | A | 44.86 | 19,000 | 852,340 | 19,000 | |
| Jan 30 2006 | KOSP | KOS PHARMACEUTICAL ... | MCGOVERN MARK E | EVP, Chief Medical ... | Grant | A | 0.00 | 9,500 | 0 | 14,063 | 4.6 K to 14.1 K (+208.20 %) |
| Jan 04 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Option Exercise | M | 19.50 | 5,000 | 97,500 | 71,000 | |
| Jan 04 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Sell | S | 50.38 | 5,000 | 251,924 | 3,788 | 8.8 K to 3.8 K (-56.90 %) |
| Jan 04 2006 | KOSP | KOS PHARMACEUTICAL ... | KING RICHARD | EVP, Commercial Ope ... | Buy | M | 19.50 | 5,000 | 97,500 | 8,788 | 3.8 K to 8.8 K (+132.00 %) |
| Dec 28 2005 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 8,922 | 0 | 4,203,985 | 4.2 M to 4.2 M (+0.21 %) |
| Dec 28 2005 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MARY | 10% Owner | Gift | G | 0.00 | 16,923 | 0 | 4,195,063 | 4.2 M to 4.2 M (+0.41 %) |
| Dec 28 2005 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS KATHRYN | 10% Owner | Gift | G | 0.00 | 68,454 | 0 | 166,575 | 98.1 K to 166.6 K (+69.76 %) |
| Dec 28 2005 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 8,922 | 0 | 4,203,985 | 4.2 M to 4.2 M (+0.21 %) |
| Dec 28 2005 | KOSP | KOS PHARMACEUTICAL ... | JAHARIS MICHAEL | Director | Gift | G | 0.00 | 16,923 | 0 | 4,195,063 | 4.2 M to 4.2 M (+0.41 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.88 | 100 | 7,088 | 0 | 100 to 0 (-100.00 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.85 | 100 | 7,085 | 100 | 200 to 100 (-50.00 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.80 | 14,600 | 1,033,680 | 200 | 14.8 K to 200 (-98.65 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.25 | 1,000 | 70,250 | 14,800 | 15.8 K to 14.8 K (-6.33 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.22 | 100 | 7,022 | 15,800 | 15.9 K to 15.8 K (-0.63 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.18 | 601 | 42,178 | 15,900 | 16.5 K to 15.9 K (-3.64 %) |
| Dec 16 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 70.15 | 1,099 | 77,095 | 16,501 | 17.6 K to 16.5 K (-6.24 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.75 | 200 | 14,350 | 17,600 | 17.8 K to 17.6 K (-1.12 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.72 | 1,201 | 86,136 | 17,800 | 19 K to 17.8 K (-6.32 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.71 | 299 | 21,441 | 19,001 | 19.3 K to 19 K (-1.55 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.70 | 208 | 14,914 | 19,300 | 19.5 K to 19.3 K (-1.07 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.60 | 192 | 13,747 | 19,508 | 19.7 K to 19.5 K (-0.97 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.44 | 200 | 14,288 | 19,700 | 19.9 K to 19.7 K (-1.01 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.41 | 200 | 14,282 | 19,900 | 20.1 K to 19.9 K (-1.00 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.40 | 800 | 57,120 | 20,100 | 20.9 K to 20.1 K (-3.83 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.39 | 100 | 7,139 | 20,900 | 21 K to 20.9 K (-0.48 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.38 | 400 | 28,552 | 21,000 | 21.4 K to 21 K (-1.87 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.37 | 300 | 21,411 | 21,400 | 21.7 K to 21.4 K (-1.38 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.36 | 100 | 7,136 | 21,700 | 21.8 K to 21.7 K (-0.46 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.33 | 500 | 35,665 | 21,800 | 22.3 K to 21.8 K (-2.24 %) |
| Dec 12 2005 | KOSP | KOS PHARMACEUTICAL ... | WHITTEMORE FREDERICK B | Director | Sell | S | 71.32 | 100 | 7,132 | 22,300 | 22.4 K to 22.3 K (-0.45 %) |